CEO & Director, Global Cannabis Applications Corp.
With over 20 years of proven business leadership from start-ups to Fortune 500 companies, Brad entered the medical cannabis industry in 2017, with a vision of using advanced technologies to create a better outcome for medical cannabis patients.
Brad's company, Global Cannabis Applications Corp, has developed a patent-pending technology infrastructure based on the integration of the Ethereum blockchain, mobile technology, machine learning, and a simple QR code. The platform, Efixii, connects a cultivator to a consumer by recording each step of cultivation-consumption on a per gram basis. Each record is attested to on the immutable blockchain for the purpose of creating data points that can be analyzed to determine an averaged efficacy of a specific product when used to treat a specific ailment at a given point in time under a set of defined circumstances. GCAC defines this process in its 2019 Patent “Cannabis on the Blockchain” using the trademark, “Seed2Seed” Brad Holds an MBA from Royal Roads University.